Montelukast Sodium Sandoz (Montelukast)

Montelukast works by selectively blocking the cysteinyl leukotriene receptor CysLT1. This inhibition prevents leukotrienes D4, E4 and related molecules from triggering bronchoconstriction, mucus production and inflammation in the airways, thereby improving breathing and reducing allergic nasal symptoms.

The appropriate dose of Montelukast is determined by the prescribing healthcare professional based on the patient’s age, condition and response to therapy. Patients should follow the exact dosing instructions provided by their prescriber and not adjust the dose on their own.

Safety data for Montelukast during pregnancy and lactation are limited, and the pregnancy category is not definitively established. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team then responds with pricing, availability, shipping details and any necessary import documentation.

Montelukast and inhaled corticosteroids target different pathways. Montelukast blocks leukotriene receptors, while inhaled corticosteroids reduce broad airway inflammation. Montelukast is often used as an add‑on therapy or alternative for patients who cannot tolerate steroids, but it is not a substitute for inhaled corticosteroids in severe asthma where steroids remain first‑line.

Montelukast tablets should be stored at room temperature, below 25 °C, in the original packaging to protect them from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Montelukast is taken orally, usually once daily in the evening, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the specific timing and administration instructions given by their prescriber.

Serious risks include allergic reactions such as rash, angioedema or anaphylaxis, and neuropsychiatric events like depression, mood swings, or suicidal thoughts. Patients should seek immediate medical attention if they experience any signs of severe allergic response or significant changes in mood or behavior.

Montelukast should not be used by individuals with a known hypersensitivity to montelukast or any of its excipients. Caution is advised for patients with severe liver impairment, and it is generally avoided in patients who have experienced serious neuropsychiatric reactions to the drug.